Sinovac Biotech Ltd
SVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001084201
No open-market purchases or sales by Sinovac Biotech Ltd insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Sinovac Biotech Ltd changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 8 | 26 | +18 |
| Shares | 3.12M | 16.5M | +13.4M (+430.4%) |
| Value | $342.0M | $80.7M | −$261.3M (−76.4%) |
New holders (18)
Institutions that held Sinovac Biotech Ltd at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vivo Capital, LLC | 11,800,000 | $76.3M | 6.00% |
| State Street Corp | 160,875 | $1.04M | 0.00% |
| Renaissance Technologies LLC | 1,312,520 | $849.0K | 0.00% |
| Geode Capital Management, LLC | 27,717 | $179.3K | 0.00% |
| Susquehanna International Group, LLP | 16,430 | $106.3K | 0.00% |
| Wells Fargo & Company | 12,750 | $82.5K | 0.00% |
| Morgan Stanley | 6,924 | $44.8K | 0.00% |
| JPMorgan Chase & Co | 3,000 | $19.4K | 0.00% |
| UBS Group AG | 2,095 | $13.6K | 0.00% |
| Group One Trading, L.P. | 412 | $2.67K | 0.00% |
| Bank of America Corp | 526 | $0 | 0.00% |
| Clearstead Advisors, LLC | 500 | $0 | 0.00% |
| Royal Bank of Canada | 533 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 424 | $0 | 0.00% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $0 | 0.00% |
| Spark Investment Management LLC | 29,100 | $0 | 0.00% |
| EverSource Wealth Advisors, LLC | 4 | $0 | 0.00% |
| Atlantic Edge Private Wealth Management, LLC | 1,000 | $0 | 0.00% |
Sold out (0)
Institutions that held Sinovac Biotech Ltd at the end of Q4 2023 and filed for Q1 2024 without it.
None.